News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Discontinued (World)
Johnson & Johnson (JNJ) Quits Multibillion-Dollar Hep C Drug Program, Partners' Stocks Fall 9/13/2017
GlaxoSmithKline (GSK) CEO Kills 30+ Pre-Clinical and Clinical Programs 7/28/2017
Brace Yourself: GlaxoSmithKline (GSK)'s New CEO Gets Ready to Overhaul the Drug Pipeline 7/25/2017
e-Therapeutics' New CEO Takes The Ax To Four Drug Discovery Programs 7/24/2017
Daiichi Sankyo Abandons 6 Clinical Programs in Q1 Update 5/12/2017
Astellas (ALPMY) Dumps Lung Cancer Program After Phase III Data Fails To Impress 5/11/2017
AstraZeneca PLC (AZN) Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More 4/28/2017
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender 4/28/2017
Novogen (NVGN) Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs 4/6/2017
NeuroDerm (NDRM) to Discontinue ND0612H Phase III, Suspend iNDiGO After FDA Meeting 12/5/2016
In 3Q Report, Shire (SHPG) Breaks Out Data From Baxalta (BXLT) Acquisition and Announces Several Program Terminations 11/2/2016
Novo Nordisk A/S (NVO) Bids Adieu to Oral Insulin, Shakes Up R&D for Growth 11/1/2016
Shire (SHPG) Kills Baxalta (BXLT)'s Hemophilia B Program; Clears Path for BioMarin (BMRN), Spark Therapeutics (ONCE) and uniQure (QURE) 8/4/2016
Mologen (MOLGF.PK) Restructures, Pushes Immunology Program, Shelves Renal Cancer Vaccine 6/9/2016
GlaxoSmithKline (GSK) Kills U.S. Part of Eczema Treatment Deal With Basilea (BSLN.SW) 1/22/2016
Janssen Pharmaceutical, Medivir (MVRBF) Terminate AL-704 Phase I for Treatment of Hepatitis C 12/22/2015
Nuvo Research (NRI.TO) to Discontinue all WF10 Development 12/21/2015
Threshold Pharma (THLD) Crumbles as Merck KGaA (MKGAF.PK) Abandons Cancer Drug After Trial Failures 12/7/2015
Medivir (MVRBF) Terminates the ADAM8 Inhibitor Project for Pancreatic Cancer 11/17/2015
NeuroVive (NVP)'s OCB-030 Preclinical Program Has Been Discontinued By Arbutus Biopharma (ABUS) 10/28/2015
GI Dynamics (GID.AX) Discontinues U.S. Trial of EndoBarrier Therapy 7/30/2015
Roche (RHHBY) Provides Update On Gantenerumab Development Programme 12/19/2014
H. Lundbeck A/S (LUN.CO) Will Halt Studies Into Vampire Bat Saliva Drug 12/19/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Traders Wobble On Merck KGaA (MKGAF.PK) After Stimuvax Stop 9/12/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/20/2014
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/12/2013
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/4/2013
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns 5/7/2013
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy 4/19/2013
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML 4/3/2013
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study 3/21/2013
Moberg Derma Discontinues Clinical Development of Limtop 3/11/2013
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug 2/13/2013
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor 12/3/2012
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects 11/7/2012
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt 10/12/2012
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study 10/11/2012
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic 10/8/2012
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial 10/3/2012
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug 10/2/2012
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems 9/17/2012
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug 9/10/2012
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss 8/27/2012
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped 6/5/2012
Q-Med AB Discontinues the Breast Indication for Macrolane 4/17/2012
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox 12/5/2011
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study 11/29/2011
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer 11/28/2011
Moberg Derma Discontinues Preclinical Development Program for A-Fizz 10/27/2011
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug 10/10/2011
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug 9/29/2011
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program 8/8/2011
BeiLu Pharma Gives Up on Melatonin-based Depression Drug 7/19/2011
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab 6/28/2011
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product 6/24/2011
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine 5/5/2011
AstraZeneca PLC (AZN) Pulls Bloodthinner In France 3/24/2011
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries 2/15/2011
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations 12/15/2010
Roche (RHHBY) and Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Decision to Discontinue Phase 3 Ocrelizumab Clinical Development Program in Patients with Rheumatoid Arthritis 5/19/2010
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15% 4/29/2009
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound 11/17/2008
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts 10/8/2008
Life Science Weekly inSite (Sep. 29 - Oct. 3) 10/6/2008
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer 7/16/2008